CRL · Healthcare · $14.2B
After-hours $286.830.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“매출이 3년 만에 처음으로 전년 대비 성장(+0.1%)으로 돌아섰어요 — 직전 4개 분기 연속 감소에서 반전이에요.”
In the company's words · 2026 2분기 earnings call